News & Events about Stockal+Disclaimer.pdf.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. (Cue Health or the Company) (NASDAQ: HLTH) for violations of the securities laws. The investigation focuses on whether the Company issued false...
Cue Health (Cue) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its molecular test to detect the mpox virus (formerly known as monkeypox). This nucleic acid...
Cue Health (Cue) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits. These easy-to-use kits provide individuals with access to accurate, reliable testing from the comfort of their own homes, making...
Cue Health Inc. (NASDAQ:HLTH Get Rating) insider Clint Sever sold 26,664 shares of the stock in a transaction dated Thursday, October 27th. The shares were sold at an average price of $3.63, for a total value of $96,790.32. Following the completion of the sale, the insider now owns 3,950,280...
Cue Health Inc. (Cue) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30...